Phyllodes Tumors: Understanding Behavior, Treatment, and Prognosis
Phyllodes tumors are rare fibroepithelial breast neoplasms (<1% of breast tumors) with a spectrum of behavior: benign, borderline, and malignant.
Key Facts
- Not typically fatal: Most are benign; malignant phyllodes have metastatic potential but rarely cause death.
- Locally aggressive: All subtypes can grow rapidly and recur if inadequately excised.
- Metastasis: Malignant phyllodes metastasize hematogenously (lung, bone) in ~10–25%; benign/borderline rarely metastasize.
- Diagnosis: Core biopsy; excision required for definitive classification.
Treatment
- Wide local excision with ≥1 cm margins (gold standard)
- Mastectomy for large or recurrent tumors
- Radiation for close or positive margins or malignant subtype
- Chemotherapy role unclear (sarcoma protocols sometimes used for metastatic disease)
Follow-Up
Clinical exam and imaging every 6–12 months for 5+ years (recurrence peaks at 1–2 years).
Prognosis
Excellent for benign; 5-year survival >90% for malignant with adequate surgery. Multidisciplinary care is recommended.
Tumors - Related Articles
- Keratosis Pilaris: Causes, Treatments, and Management Tips for "Chicken Skin"
- Uterine Cysts: Symptoms, Causes & Treatment Options
- Laetrile: Origins, History, and FDA Ban - A Comprehensive Overview
- Meningioma: Understanding Brain and Spinal Cord Tumors
- Hepatic Hemangioma: Symptoms, Causes & What to Expect
- Situs Inversus in Fetus: Diagnosis, Associations, and Pregnancy Management
- Stomach Cancer: Symptoms, Risk Factors & Detection
